Published: 04 March, 2021 | Volume 5 - Issue 1 | Pages: 005-034
Figure 1:
The workflow of developing RNAi therapeutics and translating them for clinical applications. There are mainly four steps for this, including targeting gene selection, compound screening, clinical evaluation, and market release. Imaging methods could assist the development of RNAi therapeutics at every step in the RNAi therapeutics development processes, including marking for gene selection, tracing the small RNA sequences for pharmacokinetics study, evaluating the gene-silencing efficacy, and diagnosing tumors and monitoring the therapeutic effects.
Read Full Article HTML DOI: 10.29328/journal.jro.1001035 Cite this Article Read Full Article PDF
HSPI: We're glad you're here. Please click "create a new Query" if you are a new visitor to our website and need further information from us.
If you are already a member of our network and need to keep track of any developments regarding a question you have already submitted, click "take me to my Query."